A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma
Abstract Background Radiological monitoring of malignant pleural mesothelioma (MPM) using modified RECIST criteria is limited by low sensitivity and inter-observer variability. Serial serum mesothelin measurement has shown utility in the assessment of treatment response during chemotherapy but has n...
Main Authors: | Duneesha de Fonseka, David T. Arnold, Louise Stadon, Anna Morley, Emma Keenan, Michael Darby, Lynne Armstrong, Paul Virgo, Nick A. Maskell |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4113-3 |
Similar Items
-
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
by: Duneesha de Fonseka, et al.
Published: (2018-08-01) -
Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma
by: Wafaa M. Ashour, et al.
Published: (2012-07-01) -
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
by: Laura Castelletti, et al.
Published: (2021-02-01) -
Mesothelin and osteopontin as diagnostic and prognostic markers of malignant pleural mesothelioma in Egyptian patients undergoing pleurodesis
by: Fawzy M. Amany, et al.
Published: (2013-01-01) -
Mesothelin Gene Variants Affect Soluble Mesothelin-Related Protein Levels in the Plasma of Asbestos-Exposed Males and Mesothelioma Patients from Germany
by: Hans-Peter Rihs, et al.
Published: (2022-12-01)